CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents		$ 67,944	$ 101,008
Restricted cash and restricted investments		54,409	20,080
Accounts receivable, net	[1]	107,506	75,667
Prepaid expenses and other current assets	[1]	25,449	28,488
Investments, at amortized cost		1,413	1,807
Contract assets		1,752	1,751
Total current assets		258,473	228,801
Restricted cash and restricted investments		8,262	8,260
Investments, at amortized cost		17,866	16,751
Investments in and advances to equity method investees		75,074	122,618
Property and equipment, net		85,808	85,155
Right-of-use assets - operating		63,038	72,173
Customer advance for regulatory capital requirements, net of allowances	[1]	39,955	40,000
Prepaid expenses and other noncurrent assets, net of allowances	[1]	5,801	6,253
Contract assets		860	999
Contract cost assets		34,193	36,482
Intangible assets, net		291,627	308,459
Goodwill		569,797	572,064
Total assets		1,450,754	1,498,015
Current liabilities:
Accounts payable	[1]	80,035	37,488
Accrued liabilities	[1]	28,203	33,343
Operating lease liability - current		5,785	6,269
Accrued compensation and employee benefits		16,195	34,691
Deferred revenue		17,023	19,828
Reserve for claims and performance-based arrangements	[1]	89,010	61,150
Total current liabilities		236,251	192,769
Long-term debt, net of discount		296,676	293,667
Other long-term liabilities		7,664	11,732
Operating lease liabilities - noncurrent		60,961	68,858
Deferred tax liabilities, net		2,130	1,942
Total liabilities		603,682	568,968
Commitments and Contingencies (See Note 10)
Shareholders' Equity (Deficit)
Additional paid-in-capital		1,180,288	1,173,708
Accumulated other comprehensive income (loss)		(387)	(234)
Retained earnings (accumulated deficit)		(333,684)	(251,962)
Total shareholders' equity (deficit) attributable to Evolent Health, Inc.		847,072	922,358
Non-controlling interests		0	6,689
Total shareholders' equity (deficit)		847,072	929,047
Total liabilities and shareholders' equity (deficit)		1,450,754	1,498,015
Class A Common Stock
Shareholders' Equity (Deficit)
Common stock		$ 855	$ 846

[1] See Note 18 for amounts attributable to related parties included in these line items.